Salicylic acid toners do not require pre-market approval from the FDA in the way that prescription drugs do, but they are regulated as OTC drugs if they carry acne or exfoliation treatment claims, and that classification carries significant compliance obligations.
The FDA governs SA-based acne products under the OTC Acne Monograph (21 CFR Part 333, Subpart D). Salicylic acid is an approved OTC acne active at concentrations of 0.5% to 2% in rinse-off or leave-on formulations. If your product label or advertising states it treats acne, unclogs pores, or controls breakouts, the product is legally a drug — not a cosmetic — and must comply with all OTC drug rules.
Those rules include: manufacturing at an FDA-registered drug facility following current Good Manufacturing Practice (cGMP) for drugs; printing a Drug Facts panel in the required format (active ingredient, purpose, directions, warnings); maintaining complete batch production records; and ensuring every ingredient is permissible under the monograph or has been separately cleared.
If you market the same product with purely cosmetic claims — 'tones and refines the look of skin,' for example — and make no reference to acne treatment, pore treatment, or exfoliation as a therapeutic benefit, the FDA may treat it as a cosmetic. Cosmetics are not pre-approved but must still be safe for use and properly labeled under the Federal Food, Drug, and Cosmetic Act as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). MoCRA now requires cosmetic facility registration and product listing for brands with annual US revenue above $1M (smaller brands have a phased-in timeline).
The practical risk of getting this wrong is significant. Selling a 2% SA toner with acne claims from a cosmetics-only facility is an FDA violation and can result in warning letters, import holds, or product recalls. When evaluating manufacturers through AJ Cosmo Labs, always ask the lab directly whether their facility holds a drug establishment registration (you can verify in FDA's database at fda.gov) and whether they have produced OTC acne products before.
For international sales: the EU does not have the same OTC monograph system. In the EU, a SA toner at up to 2% SA with appropriate rinsing caveats may qualify as a cosmetic governed by EU Regulation 1223/2009, subject to a Cosmetic Product Safety Report and CPNP notification. Prop 65 in California requires a warning if SA concentrations or formulation byproducts exceed established thresholds — confirm with your manufacturer.
Ingredients in this answer: Salicylic Acid
Read the full guide on Private Label Salicylic Acid Toner Manufacturer USA →